nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—Application site exfoliation—Tazarotene—psoriasis	0.0992	0.179	CcSEcCtD
Ingenol Mebutate—Application site erythema—Calcipotriol—psoriasis	0.0344	0.062	CcSEcCtD
Ingenol Mebutate—PRKCA—skin epidermis—psoriasis	0.0307	0.307	CbGeAlD
Ingenol Mebutate—Application site erythema—Tazarotene—psoriasis	0.0254	0.0457	CcSEcCtD
Ingenol Mebutate—Instillation site pain—Calcipotriol—psoriasis	0.0249	0.0448	CcSEcCtD
Ingenol Mebutate—Application site pruritus—Tazarotene—psoriasis	0.0245	0.0441	CcSEcCtD
Ingenol Mebutate—Application site burn—Clobetasol propionate—psoriasis	0.0242	0.0436	CcSEcCtD
Ingenol Mebutate—PRKCA—endothelium—psoriasis	0.0223	0.223	CbGeAlD
Ingenol Mebutate—Application site burn—Fluocinonide—psoriasis	0.0218	0.0393	CcSEcCtD
Ingenol Mebutate—Application site irritation—Tazarotene—psoriasis	0.0215	0.0388	CcSEcCtD
Ingenol Mebutate—Application site pruritus—Clobetasol propionate—psoriasis	0.0208	0.0374	CcSEcCtD
Ingenol Mebutate—Application site pain—Calcipotriol—psoriasis	0.0184	0.0332	CcSEcCtD
Ingenol Mebutate—Instillation site pain—Tazarotene—psoriasis	0.0183	0.0331	CcSEcCtD
Ingenol Mebutate—Application site irritation—Clobetasol propionate—psoriasis	0.0183	0.0329	CcSEcCtD
Ingenol Mebutate—PRKCD—skin of body—psoriasis	0.0173	0.172	CbGeAlD
Ingenol Mebutate—Instillation site pain—Clobetasol propionate—psoriasis	0.0155	0.028	CcSEcCtD
Ingenol Mebutate—Application site pain—Tazarotene—psoriasis	0.0136	0.0245	CcSEcCtD
Ingenol Mebutate—PRKCD—tendon—psoriasis	0.0131	0.131	CbGeAlD
Ingenol Mebutate—Application site pain—Clobetasol propionate—psoriasis	0.0115	0.0208	CcSEcCtD
Ingenol Mebutate—Application site pain—Fluocinonide—psoriasis	0.0104	0.0187	CcSEcCtD
Ingenol Mebutate—PRKCA—skin of body—psoriasis	0.00952	0.095	CbGeAlD
Ingenol Mebutate—Scab—Acitretin—psoriasis	0.00899	0.0162	CcSEcCtD
Ingenol Mebutate—PRKCA—tendon—psoriasis	0.00725	0.0723	CbGeAlD
Ingenol Mebutate—Application site burn—Hydrocortisone—psoriasis	0.00645	0.0116	CcSEcCtD
Ingenol Mebutate—Eyelid oedema—Fluocinolone Acetonide—psoriasis	0.00565	0.0102	CcSEcCtD
Ingenol Mebutate—Swelling—Tazarotene—psoriasis	0.00492	0.00887	CcSEcCtD
Ingenol Mebutate—Ulcer—Beclomethasone—psoriasis	0.00488	0.00879	CcSEcCtD
Ingenol Mebutate—Application site irritation—Hydrocortisone—psoriasis	0.00487	0.00878	CcSEcCtD
Ingenol Mebutate—Swelling—Fluocinonide—psoriasis	0.00376	0.00678	CcSEcCtD
Ingenol Mebutate—Erythema—Calcipotriol—psoriasis	0.00354	0.00639	CcSEcCtD
Ingenol Mebutate—Application site pain—Hydrocortisone—psoriasis	0.00307	0.00554	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Beclomethasone—psoriasis	0.00299	0.0054	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Fluocinonide—psoriasis	0.00297	0.00535	CcSEcCtD
Ingenol Mebutate—Erythema—Tazarotene—psoriasis	0.00261	0.00471	CcSEcCtD
Ingenol Mebutate—Ulcer—Hydroxyurea—psoriasis	0.00237	0.00428	CcSEcCtD
Ingenol Mebutate—Eye pain—Acitretin—psoriasis	0.0023	0.00415	CcSEcCtD
Ingenol Mebutate—Eye pain—Fluocinolone Acetonide—psoriasis	0.00229	0.00413	CcSEcCtD
Ingenol Mebutate—Erythema—Clobetasol propionate—psoriasis	0.00221	0.00399	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Calcitriol—psoriasis	0.00209	0.00376	CcSEcCtD
Ingenol Mebutate—Erythema—Fluocinonide—psoriasis	0.002	0.0036	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Fluocinolone Acetonide—psoriasis	0.00185	0.00334	CcSEcCtD
Ingenol Mebutate—Infection—Clobetasol propionate—psoriasis	0.0018	0.00324	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Calcitriol—psoriasis	0.00175	0.00315	CcSEcCtD
Ingenol Mebutate—Infection—Beclomethasone—psoriasis	0.00163	0.00295	CcSEcCtD
Ingenol Mebutate—Infection—Fluocinonide—psoriasis	0.00162	0.00292	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Fluocinonide—psoriasis	0.0016	0.00288	CcSEcCtD
Ingenol Mebutate—Infestation—Fluocinolone Acetonide—psoriasis	0.0016	0.00288	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Fluocinolone Acetonide—psoriasis	0.0016	0.00288	CcSEcCtD
Ingenol Mebutate—Erythema—Methoxsalen—psoriasis	0.00158	0.00284	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Acitretin—psoriasis	0.00156	0.0028	CcSEcCtD
Ingenol Mebutate—Swelling—Mycophenolic acid—psoriasis	0.00155	0.00279	CcSEcCtD
Ingenol Mebutate—Erythema—Calcitriol—psoriasis	0.00141	0.00253	CcSEcCtD
Ingenol Mebutate—Ulcer—Triamcinolone—psoriasis	0.00135	0.00243	CcSEcCtD
Ingenol Mebutate—Eye disorder—Acitretin—psoriasis	0.00134	0.00242	CcSEcCtD
Ingenol Mebutate—Eye disorder—Fluocinolone Acetonide—psoriasis	0.00134	0.00241	CcSEcCtD
Ingenol Mebutate—Infection—Methoxsalen—psoriasis	0.00128	0.00231	CcSEcCtD
Ingenol Mebutate—Infestation—Hydroxyurea—psoriasis	0.00126	0.00226	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Hydroxyurea—psoriasis	0.00126	0.00226	CcSEcCtD
Ingenol Mebutate—Erythema—Acitretin—psoriasis	0.00125	0.00225	CcSEcCtD
Ingenol Mebutate—Erythema—Fluocinolone Acetonide—psoriasis	0.00125	0.00225	CcSEcCtD
Ingenol Mebutate—Eye pain—Cyclosporine—psoriasis	0.00122	0.00221	CcSEcCtD
Ingenol Mebutate—Ulcer—Betamethasone—psoriasis	0.00122	0.0022	CcSEcCtD
Ingenol Mebutate—Ulcer—Dexamethasone—psoriasis	0.00122	0.0022	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Mycophenolic acid—psoriasis	0.00122	0.0022	CcSEcCtD
Ingenol Mebutate—Eye pain—Mycophenolate mofetil—psoriasis	0.00119	0.00215	CcSEcCtD
Ingenol Mebutate—Headache—Clobetasol propionate—psoriasis	0.00113	0.00204	CcSEcCtD
Ingenol Mebutate—Ulcer—Prednisone—psoriasis	0.00106	0.00192	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Mycophenolic acid—psoriasis	0.00105	0.0019	CcSEcCtD
Ingenol Mebutate—Infestation—Mycophenolic acid—psoriasis	0.00105	0.0019	CcSEcCtD
Ingenol Mebutate—Headache—Beclomethasone—psoriasis	0.00103	0.00186	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Mycophenolic acid—psoriasis	0.00102	0.00184	CcSEcCtD
Ingenol Mebutate—Headache—Fluocinonide—psoriasis	0.00102	0.00184	CcSEcCtD
Ingenol Mebutate—Infection—Acitretin—psoriasis	0.00101	0.00183	CcSEcCtD
Ingenol Mebutate—Infection—Fluocinolone Acetonide—psoriasis	0.00101	0.00182	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Fluocinolone Acetonide—psoriasis	0.000998	0.0018	CcSEcCtD
Ingenol Mebutate—Erythema—Hydroxyurea—psoriasis	0.000982	0.00177	CcSEcCtD
Ingenol Mebutate—Eye pain—Betamethasone—psoriasis	0.000929	0.00167	CcSEcCtD
Ingenol Mebutate—Eye pain—Dexamethasone—psoriasis	0.000929	0.00167	CcSEcCtD
Ingenol Mebutate—Ulcer—Methotrexate—psoriasis	0.000889	0.0016	CcSEcCtD
Ingenol Mebutate—Eye disorder—Mycophenolic acid—psoriasis	0.000883	0.00159	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Cyclosporine—psoriasis	0.000851	0.00153	CcSEcCtD
Ingenol Mebutate—Infestation—Cyclosporine—psoriasis	0.000851	0.00153	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Mycophenolate mofetil—psoriasis	0.00083	0.0015	CcSEcCtD
Ingenol Mebutate—Infestation—Mycophenolate mofetil—psoriasis	0.00083	0.0015	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Cyclosporine—psoriasis	0.000827	0.00149	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Mycophenolate mofetil—psoriasis	0.000807	0.00146	CcSEcCtD
Ingenol Mebutate—Headache—Methoxsalen—psoriasis	0.000806	0.00145	CcSEcCtD
Ingenol Mebutate—Infection—Hydroxyurea—psoriasis	0.000796	0.00144	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Hydroxyurea—psoriasis	0.000786	0.00142	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Hydrocortisone—psoriasis	0.000756	0.00136	CcSEcCtD
Ingenol Mebutate—Infestation—Hydrocortisone—psoriasis	0.000756	0.00136	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Prednisolone—psoriasis	0.000753	0.00136	CcSEcCtD
Ingenol Mebutate—Headache—Calcitriol—psoriasis	0.000719	0.0013	CcSEcCtD
Ingenol Mebutate—Eye disorder—Mycophenolate mofetil—psoriasis	0.000697	0.00126	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Triamcinolone—psoriasis	0.000692	0.00125	CcSEcCtD
Ingenol Mebutate—Infection—Mycophenolic acid—psoriasis	0.000667	0.0012	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Mycophenolic acid—psoriasis	0.000658	0.00119	CcSEcCtD
Ingenol Mebutate—Headache—Acitretin—psoriasis	0.000639	0.00115	CcSEcCtD
Ingenol Mebutate—Headache—Fluocinolone Acetonide—psoriasis	0.000637	0.00115	CcSEcCtD
Ingenol Mebutate—Eye disorder—Hydrocortisone—psoriasis	0.000635	0.00114	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Betamethasone—psoriasis	0.000628	0.00113	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Dexamethasone—psoriasis	0.000628	0.00113	CcSEcCtD
Ingenol Mebutate—Erythema—Prednisolone—psoriasis	0.000605	0.00109	CcSEcCtD
Ingenol Mebutate—Erythema—Hydrocortisone—psoriasis	0.000591	0.00107	CcSEcCtD
Ingenol Mebutate—Erythema—Triamcinolone—psoriasis	0.000557	0.001	CcSEcCtD
Ingenol Mebutate—Eye disorder—Betamethasone—psoriasis	0.000542	0.000978	CcSEcCtD
Ingenol Mebutate—Eye disorder—Dexamethasone—psoriasis	0.000542	0.000978	CcSEcCtD
Ingenol Mebutate—Infection—Cyclosporine—psoriasis	0.000539	0.000972	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Cyclosporine—psoriasis	0.000532	0.00096	CcSEcCtD
Ingenol Mebutate—Infection—Mycophenolate mofetil—psoriasis	0.000526	0.000949	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling by VEGF—TYK2—psoriasis	0.00052	0.00151	CbGpPWpGaD
Ingenol Mebutate—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000519	0.000936	CcSEcCtD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCL20—psoriasis	0.000512	0.00148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—TP53—psoriasis	0.000509	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TAGAP—psoriasis	0.000505	0.00146	CbGpPWpGaD
Ingenol Mebutate—Erythema—Dexamethasone—psoriasis	0.000505	0.000911	CcSEcCtD
Ingenol Mebutate—Erythema—Betamethasone—psoriasis	0.000505	0.000911	CcSEcCtD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000504	0.00146	CbGpPWpGaD
Ingenol Mebutate—Headache—Hydroxyurea—psoriasis	0.000502	0.000905	CcSEcCtD
Ingenol Mebutate—PRKCA—Downstream signaling in naïve CD8+ T cells—TNF—psoriasis	0.000492	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000485	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—STAT3—psoriasis	0.000485	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—STAT3—psoriasis	0.000482	0.0014	CbGpPWpGaD
Ingenol Mebutate—Infection—Hydrocortisone—psoriasis	0.000479	0.000864	CcSEcCtD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IFNG—psoriasis	0.000477	0.00138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—ITGAL—psoriasis	0.000473	0.00137	CbGpPWpGaD
Ingenol Mebutate—Nervous system disorder—Hydrocortisone—psoriasis	0.000473	0.000853	CcSEcCtD
Ingenol Mebutate—Eye disorder—Prednisone—psoriasis	0.000472	0.000851	CcSEcCtD
Ingenol Mebutate—Infestation—Methotrexate—psoriasis	0.00047	0.000848	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Methotrexate—psoriasis	0.00047	0.000848	CcSEcCtD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—IL6—psoriasis	0.000469	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	0.000468	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—JUN—psoriasis	0.000463	0.00134	CbGpPWpGaD
Ingenol Mebutate—Conjunctivitis—Methotrexate—psoriasis	0.000457	0.000824	CcSEcCtD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—JUN—psoriasis	0.000453	0.00131	CbGpPWpGaD
Ingenol Mebutate—Infection—Triamcinolone—psoriasis	0.000451	0.000814	CcSEcCtD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—STAT3—psoriasis	0.000449	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—TYK2—psoriasis	0.000444	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—CXCL8—psoriasis	0.000444	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—IL6—psoriasis	0.000443	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—SOCS1—psoriasis	0.000442	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—TYK2—psoriasis	0.000442	0.00128	CbGpPWpGaD
Ingenol Mebutate—Erythema—Prednisone—psoriasis	0.00044	0.000793	CcSEcCtD
Ingenol Mebutate—PRKCD—Signaling by PDGF—STAT3—psoriasis	0.000439	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TP53—psoriasis	0.000439	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—TYK2—psoriasis	0.000437	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ATF-2 transcription factor network—IL6—psoriasis	0.000434	0.00126	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TNF—psoriasis	0.000432	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ITGAL—psoriasis	0.000432	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NDUFA5—psoriasis	0.000426	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000423	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—TYK2—psoriasis	0.000423	0.00122	CbGpPWpGaD
Ingenol Mebutate—Headache—Mycophenolic acid—psoriasis	0.00042	0.000758	CcSEcCtD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IFNG—psoriasis	0.000416	0.00121	CbGpPWpGaD
Ingenol Mebutate—Infection—Dexamethasone—psoriasis	0.000409	0.000738	CcSEcCtD
Ingenol Mebutate—Infection—Betamethasone—psoriasis	0.000409	0.000738	CcSEcCtD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TNF—psoriasis	0.000405	0.00117	CbGpPWpGaD
Ingenol Mebutate—Nervous system disorder—Betamethasone—psoriasis	0.000404	0.000729	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Dexamethasone—psoriasis	0.000404	0.000729	CcSEcCtD
Ingenol Mebutate—PRKCD—Immune System—REL—psoriasis	0.000404	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	0.000398	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—TYK2—psoriasis	0.000397	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—CARM1—psoriasis	0.000396	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—TYK2—psoriasis	0.000395	0.00115	CbGpPWpGaD
Ingenol Mebutate—Eye disorder—Methotrexate—psoriasis	0.000395	0.000711	CcSEcCtD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—JUN—psoriasis	0.000394	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—TYK2—psoriasis	0.000394	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IFIH1—psoriasis	0.000392	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—STAT3—psoriasis	0.000392	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—TYK2—psoriasis	0.000392	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—VEGFA—psoriasis	0.00039	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IFIH1—psoriasis	0.000387	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TP53—psoriasis	0.000381	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.00038	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HLA-B—psoriasis	0.000378	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERAP1—psoriasis	0.000372	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HLA-C—psoriasis	0.000372	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—TYK2—psoriasis	0.000368	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—TYK2—psoriasis	0.000368	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—VEGFA—psoriasis	0.000368	0.00107	CbGpPWpGaD
Ingenol Mebutate—Erythema—Methotrexate—psoriasis	0.000368	0.000663	CcSEcCtD
Ingenol Mebutate—PRKCD—Immune System—TNFAIP3—psoriasis	0.000367	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HLA-C—psoriasis	0.000367	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—TYK2—psoriasis	0.000365	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—psoriasis	0.000364	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—TNFAIP3—psoriasis	0.000362	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP2S1—psoriasis	0.000362	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—TYK2—psoriasis	0.000362	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—TYK2—psoriasis	0.00036	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—IL6—psoriasis	0.00036	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—psoriasis	0.000357	0.00104	CbGpPWpGaD
Ingenol Mebutate—Infection—Prednisone—psoriasis	0.000357	0.000643	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Prednisone—psoriasis	0.000352	0.000635	CcSEcCtD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	0.000349	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—NFKB1—psoriasis	0.000346	0.001	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—STAT3—psoriasis	0.000341	0.000987	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—NFKB1—psoriasis	0.00034	0.000986	CbGpPWpGaD
Ingenol Mebutate—Headache—Cyclosporine—psoriasis	0.00034	0.000613	CcSEcCtD
Ingenol Mebutate—PRKCD—Downstream signal transduction—IL6—psoriasis	0.000338	0.00098	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NOS2—psoriasis	0.000338	0.000979	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—IL6—psoriasis	0.000337	0.000976	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—IL6—psoriasis	0.000335	0.000971	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HCAR2—psoriasis	0.000335	0.000969	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CRP—psoriasis	0.000334	0.000967	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—IL6—psoriasis	0.000333	0.000966	CbGpPWpGaD
Ingenol Mebutate—Headache—Mycophenolate mofetil—psoriasis	0.000332	0.000598	CcSEcCtD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—JUN—psoriasis	0.000332	0.000961	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—ICAM1—psoriasis	0.000329	0.000954	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—DDX58—psoriasis	0.000327	0.000948	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—TYK2—psoriasis	0.000326	0.000945	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CCL20—psoriasis	0.000324	0.000939	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—JUN—psoriasis	0.000323	0.000937	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—JUN—psoriasis	0.00032	0.000927	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—NFKB1—psoriasis	0.000319	0.000925	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.000315	0.000914	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—IL6—psoriasis	0.000314	0.000909	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—IL6—psoriasis	0.000314	0.000909	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—STAT3—psoriasis	0.000311	0.000902	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—IL6—psoriasis	0.000311	0.000901	CbGpPWpGaD
Ingenol Mebutate—Headache—Prednisolone—psoriasis	0.000309	0.000558	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—STAT3—psoriasis	0.000309	0.000896	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TNF—psoriasis	0.000309	0.000895	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HLA-E—psoriasis	0.000309	0.000894	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—IL6—psoriasis	0.000308	0.000893	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—IL6—psoriasis	0.000307	0.000889	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NFKBIA—psoriasis	0.000306	0.000888	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—STAT3—psoriasis	0.000306	0.000886	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—psoriasis	0.000306	0.000886	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HLA-E—psoriasis	0.000304	0.000882	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—NFKBIA—psoriasis	0.000304	0.000882	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL20—psoriasis	0.000303	0.000877	CbGpPWpGaD
Ingenol Mebutate—Headache—Hydrocortisone—psoriasis	0.000302	0.000545	CcSEcCtD
Ingenol Mebutate—Infection—Methotrexate—psoriasis	0.000298	0.000537	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL20—psoriasis	0.000294	0.000852	CbGpPWpGaD
Ingenol Mebutate—Nervous system disorder—Methotrexate—psoriasis	0.000294	0.00053	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling Pathways—TAGAP—psoriasis	0.00029	0.00084	CbGpPWpGaD
Ingenol Mebutate—Headache—Triamcinolone—psoriasis	0.000285	0.000513	CcSEcCtD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000281	0.000813	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—STAT3—psoriasis	0.000278	0.000806	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	0.000278	0.000805	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—STAT3—psoriasis	0.000277	0.000802	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—psoriasis	0.000272	0.000789	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.00027	0.000782	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—IL6—psoriasis	0.00027	0.000781	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000269	0.000778	CbGpPWpGaD
Ingenol Mebutate—Headache—Betamethasone—psoriasis	0.000258	0.000466	CcSEcCtD
Ingenol Mebutate—Headache—Dexamethasone—psoriasis	0.000258	0.000466	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—STAT3—psoriasis	0.000258	0.000747	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—SOCS1—psoriasis	0.000258	0.000747	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—IL6—psoriasis	0.000254	0.000737	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—SOCS1—psoriasis	0.000254	0.000736	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—STAT3—psoriasis	0.000252	0.000731	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—TYK2—psoriasis	0.000251	0.000727	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—TYK2—psoriasis	0.000249	0.000722	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IL6—psoriasis	0.000249	0.000722	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ITGAL—psoriasis	0.000248	0.000719	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000245	0.00071	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—PCNA—psoriasis	0.000244	0.000706	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—VDR—psoriasis	0.000236	0.000685	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—REL—psoriasis	0.000232	0.000672	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD8A—psoriasis	0.000229	0.000662	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	0.000228	0.000662	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—CARM1—psoriasis	0.000227	0.000658	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CD4—psoriasis	0.000225	0.000653	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IFIH1—psoriasis	0.000225	0.000653	CbGpPWpGaD
Ingenol Mebutate—Headache—Prednisone—psoriasis	0.000225	0.000405	CcSEcCtD
Ingenol Mebutate—PRKCD—Immune System—HLA-B—psoriasis	0.00022	0.000637	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000218	0.000632	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—PCNA—psoriasis	0.000218	0.000632	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IL6—psoriasis	0.000217	0.00063	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HLA-B—psoriasis	0.000217	0.000628	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—IL6—psoriasis	0.000216	0.000626	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—IL6—psoriasis	0.000214	0.000619	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-C—psoriasis	0.000214	0.000619	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TNFAIP3—psoriasis	0.000211	0.000611	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	0.00021	0.000609	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—IL6—psoriasis	0.000207	0.000599	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HLA-A—psoriasis	0.000204	0.00059	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—JUN—psoriasis	0.000202	0.000584	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	0.0002	0.00058	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—VEGFA—psoriasis	0.000196	0.000567	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NFKB1—psoriasis	0.000196	0.000566	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—IL6—psoriasis	0.000194	0.000563	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CRP—psoriasis	0.000194	0.000563	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—NFKB1—psoriasis	0.000194	0.000563	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS2—psoriasis	0.000194	0.000562	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—IL6—psoriasis	0.000193	0.00056	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—IL6—psoriasis	0.000192	0.000558	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CRP—psoriasis	0.000192	0.000555	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—IL6—psoriasis	0.000192	0.000555	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HLA-A—psoriasis	0.000188	0.000545	CbGpPWpGaD
Ingenol Mebutate—Headache—Methotrexate—psoriasis	0.000188	0.000339	CcSEcCtD
Ingenol Mebutate—PRKCD—Immune System—HLA-DRB1—psoriasis	0.000186	0.000539	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.000185	0.000537	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—IL6—psoriasis	0.00018	0.000522	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—IL6—psoriasis	0.00018	0.000522	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ICAM1—psoriasis	0.000179	0.000518	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—IL6—psoriasis	0.000179	0.000517	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-E—psoriasis	0.000177	0.000513	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NFKBIA—psoriasis	0.000177	0.000513	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—IL6—psoriasis	0.000177	0.000513	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CARM1—psoriasis	0.000177	0.000512	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—IL6—psoriasis	0.000176	0.00051	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—STAT3—psoriasis	0.000176	0.000509	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—APOE—psoriasis	0.000176	0.000509	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NFKBIA—psoriasis	0.000175	0.000506	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL20—psoriasis	0.000174	0.000503	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SOCS1—psoriasis	0.000167	0.000483	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—PPARG—psoriasis	0.000165	0.000477	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS2—psoriasis	0.000164	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	0.00016	0.000462	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—TYK2—psoriasis	0.000159	0.00046	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000154	0.000447	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CXCL8—psoriasis	0.000152	0.000441	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SOCS1—psoriasis	0.000148	0.000429	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—psoriasis	0.000148	0.000429	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—TYK2—psoriasis	0.000145	0.000421	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—TYK2—psoriasis	0.000143	0.000415	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CXCL8—psoriasis	0.000138	0.000401	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IFNG—psoriasis	0.000136	0.000394	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—VDR—psoriasis	0.000136	0.000393	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TYK2—psoriasis	0.000134	0.000388	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD8A—psoriasis	0.000131	0.00038	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD4—psoriasis	0.000131	0.00038	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CD4—psoriasis	0.000129	0.000375	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-B—psoriasis	0.000126	0.000366	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—LEP—psoriasis	0.000123	0.000356	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOE—psoriasis	0.000123	0.000356	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6—psoriasis	0.000123	0.000356	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6—psoriasis	0.000122	0.000353	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CD4—psoriasis	0.000121	0.000351	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—JUN—psoriasis	0.000118	0.00034	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-A—psoriasis	0.000117	0.000339	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—JUN—psoriasis	0.000116	0.000336	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NFKBIA—psoriasis	0.000115	0.000332	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NFKB1—psoriasis	0.000113	0.000328	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—psoriasis	0.000112	0.000326	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CRP—psoriasis	0.000112	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NFKB1—psoriasis	0.000112	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CAT—psoriasis	0.000109	0.000315	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HLA-A—psoriasis	0.000108	0.000313	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-DRB1—psoriasis	0.000107	0.00031	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ICAM1—psoriasis	0.000103	0.000297	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NFKBIA—psoriasis	0.000102	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—STAT3—psoriasis	0.000102	0.000294	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOE—psoriasis	0.000101	0.000292	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SOCS1—psoriasis	9.57e-05	0.000277	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARG—psoriasis	9.46e-05	0.000274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS2—psoriasis	9.4e-05	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TYK2—psoriasis	9.39e-05	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—STAT3—psoriasis	9.38e-05	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TYK2—psoriasis	9.13e-05	0.000264	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CXCL8—psoriasis	8.75e-05	0.000253	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—psoriasis	8.5e-05	0.000246	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOE—psoriasis	8.45e-05	0.000245	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TYK2—psoriasis	8.34e-05	0.000242	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCL8—psoriasis	8.17e-05	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—psoriasis	8.02e-05	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCL8—psoriasis	7.95e-05	0.00023	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IFNG—psoriasis	7.81e-05	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—psoriasis	7.77e-05	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TYK2—psoriasis	7.7e-05	0.000223	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—JUN—psoriasis	7.6e-05	0.00022	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD4—psoriasis	7.54e-05	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARG—psoriasis	7.36e-05	0.000213	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NFKB1—psoriasis	7.31e-05	0.000212	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—psoriasis	7.1e-05	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LEP—psoriasis	7.06e-05	0.000205	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOE—psoriasis	7.06e-05	0.000205	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—psoriasis	7e-05	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CD4—psoriasis	6.96e-05	0.000202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—JUN—psoriasis	6.75e-05	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—psoriasis	6.64e-05	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NFKBIA—psoriasis	6.58e-05	0.000191	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—STAT3—psoriasis	6.57e-05	0.00019	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—psoriasis	6.56e-05	0.00019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NFKB1—psoriasis	6.5e-05	0.000188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—STAT3—psoriasis	5.84e-05	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TYK2—psoriasis	5.39e-05	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—STAT3—psoriasis	5.39e-05	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—psoriasis	5.01e-05	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL8—psoriasis	4.69e-05	0.000136	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—psoriasis	4.59e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—psoriasis	4.46e-05	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—JUN—psoriasis	4.36e-05	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NFKB1—psoriasis	4.2e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—psoriasis	4.08e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—psoriasis	3.81e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STAT3—psoriasis	3.77e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—psoriasis	3.76e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—psoriasis	2.88e-05	8.34e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—psoriasis	2.64e-05	7.64e-05	CbGpPWpGaD
